bf/NASDAQ:VIVO_icon.png

NASDAQ:VIVO

Meridian Bioscience, Inc.

  • Stock

USD

Last Close

33.97

30/01 21:00

Market Cap

1.49B

Beta: -

Volume Today

5.63M

Avg: 686.61K

PE Ratio

−551.87

PFCF: 42.66

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '15
Sep '16
Sep '17
Sep '18
Sep '19
Sep '20
Sep '21
Sep '22
net income
35.54M
-
32.23M
9.32%
21.56M
33.11%
23.85M
10.63%
24.38M
2.23%
46.19M
89.43%
71.41M
54.61%
42.46M
40.54%
depreciation and amortization
5.22M
-
6.63M
27.00%
8.12M
22.50%
7.92M
2.39%
9.96M
25.74%
13.57M
36.16%
15.29M
12.67%
16.51M
8.01%
deferred income tax
-122K
-
-233K
90.98%
1.47M
732.62%
-300K
120.35%
-817K
172.33%
760K
193.02%
-3.83M
604.61%
-1.10M
71.29%
stock based compensation
3.32M
-
2.91M
12.42%
3.38M
16.15%
3.40M
0.62%
3.25M
4.44%
3.80M
16.95%
4.16M
9.31%
6.90M
66.03%
change in working capital
-2.84M
-
-5.88M
106.90%
-54K
99.08%
-1.67M
2,985.19%
-1.04M
37.64%
-11.42M
998.94%
-18.26M
59.92%
9.84M
153.87%
accounts receivables
-4.45M
-
-2.31M
47.96%
-971K
58.04%
-12.77M
1,214.73%
4.56M
135.75%
inventory
-1.14M
-
3.84M
436.34%
-18.98M
594.06%
-7.80M
58.90%
5.22M
166.96%
accounts payables
4.12M
-
-2.31M
156.13%
7.25M
413.09%
6.35M
12.44%
1.04M
83.64%
other working capital
-2.84M
-
-5.88M
106.90%
-54K
99.08%
-201K
272.22%
-251K
24.88%
1.28M
610.76%
-4.04M
415.13%
-988K
75.54%
other non cash items
1.69M
-
1.57M
7.28%
6.88M
338.99%
1.57M
77.12%
90K
94.28%
-4.92M
5,567.78%
-1.89M
61.61%
7.75M
510.53%
net cash provided by operating activities
42.81M
-
37.22M
13.05%
41.35M
11.10%
34.78M
15.89%
35.83M
3.01%
47.98M
33.90%
66.86M
39.37%
82.36M
23.18%
investments in property plant and equipment
-4.76M
-
-4.00M
15.95%
-4.47M
11.56%
-4.20M
5.95%
-3.80M
9.62%
-3.30M
13.12%
-18.31M
455.08%
-8.62M
52.95%
acquisitions net
-62.09M
-
-45.32M
-
-51.30M
13.18%
-23.59M
54.02%
-3.75M
84.10%
purchases of investments
-600K
-
sales maturities of investments
other investing activites
1.14M
-
669K
-
1.50M
-
1.25M
16.67%
net cash used for investing activites
-3.63M
-
-66.69M
1,739.35%
-4.47M
93.30%
-4.20M
5.95%
-48.45M
1,053.34%
-54.60M
12.68%
-40.40M
26.01%
-11.12M
72.49%
debt repayment
-1.50M
-
-3.75M
150%
-4.50M
20%
-50.25M
1,016.67%
-57M
13.43%
-18.82M
66.98%
-35M
85.93%
common stock issued
common stock repurchased
dividends paid
-33.36M
-
-33.65M
0.88%
-24.27M
27.88%
-21.17M
12.76%
-10.61M
49.87%
other financing activites
2.61M
-
62.35M
2,285.39%
303K
99.51%
-1.92M
734.65%
76.12M
4,058.50%
53.44M
29.79%
-12.24M
122.91%
697K
105.69%
net cash used provided by financing activities
-30.74M
-
27.20M
188.49%
-27.71M
201.87%
-27.59M
0.43%
15.26M
155.30%
-3.56M
123.31%
-31.07M
773.46%
-34.30M
10.41%
effect of forex changes on cash
-1.51M
-
-480K
68.30%
671K
239.79%
-298K
144.41%
-1.00M
237.25%
1.30M
228.96%
858K
33.80%
-5.26M
713.17%
net change in cash
6.93M
-
-2.75M
139.66%
9.85M
458.43%
2.69M
72.67%
1.63M
39.28%
-8.88M
643.64%
-3.74M
57.86%
31.68M
946.43%
cash at beginning of period
43.05M
-
49.97M
16.09%
47.23M
5.50%
57.07M
20.85%
60.76M
6.47%
62.40M
2.69%
53.51M
14.24%
49.77M
6.99%
cash at end of period
49.97M
-
47.23M
5.50%
57.07M
20.85%
59.76M
4.72%
62.40M
4.41%
53.51M
14.24%
49.77M
6.99%
81.45M
63.66%
operating cash flow
42.81M
-
37.22M
13.05%
41.35M
11.10%
34.78M
15.89%
35.83M
3.01%
47.98M
33.90%
66.86M
39.37%
82.36M
23.18%
capital expenditure
-4.76M
-
-4.00M
15.95%
-4.47M
11.56%
-4.20M
5.95%
-3.80M
9.62%
-3.30M
13.12%
-18.31M
455.08%
-8.62M
52.95%
free cash flow
38.05M
-
33.22M
12.68%
36.89M
11.04%
30.58M
17.09%
32.03M
4.75%
44.68M
39.47%
48.55M
8.68%
73.75M
51.89%

All numbers in USD (except ratios and percentages)